CN Stock MarketDetailed Quotes

300725 Pharma Block Sciences

Watchlist
  • 33.65
  • -0.15-0.44%
Market Closed Apr 30 15:00 CST
6.72BMarket Cap35.53P/E (TTM)

Pharma Block Sciences Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-1.56%377.46M
8.18%1.73B
9.01%1.29B
14.89%844.06M
14.24%383.44M
32.71%1.59B
31.21%1.18B
18.23%734.64M
17.44%335.64M
17.55%1.2B
Operating revenue
-1.56%377.46M
8.18%1.73B
9.01%1.29B
14.89%844.06M
14.24%383.44M
32.71%1.59B
31.21%1.18B
18.23%734.64M
17.44%335.64M
17.55%1.2B
Other operating revenue
----
-7.91%451.99K
----
9.35%220.55K
----
37.32%490.8K
----
283.29%201.68K
----
168.79%357.42K
Total operating cost
-5.73%325.2M
14.73%1.49B
22.11%1.09B
28.90%705.56M
35.45%344.99M
38.40%1.3B
32.81%892.45M
20.33%547.38M
15.54%254.7M
13.72%936.62M
Operating cost
3.01%216.31M
14.05%991.67M
18.16%737.71M
23.83%475.39M
19.50%209.99M
39.49%869.5M
36.47%624.35M
22.69%383.9M
17.05%175.73M
12.48%623.34M
Operating tax surcharges
54.13%5.1M
56.71%18.63M
46.11%9.83M
71.33%7.24M
106.34%3.31M
43.63%11.89M
4.59%6.73M
-16.50%4.23M
117.41%1.6M
30.02%8.28M
Operating expense
8.08%14.12M
29.91%53.21M
32.88%41.16M
37.53%27.09M
27.24%13.06M
68.65%40.96M
26.40%30.97M
12.66%19.7M
4.79%10.26M
-20.80%24.28M
Administration expense
-4.64%47.05M
-3.52%200.23M
-0.53%148.75M
15.24%100.88M
25.03%49.33M
38.03%207.53M
47.11%149.54M
33.86%87.54M
-1.04%39.46M
24.08%150.35M
Financial expense
-61.16%8.12M
2,996.37%54.3M
148.95%19.75M
112.57%2.49M
17,016.90%20.9M
-111.47%-1.87M
-8,813.32%-40.35M
-706.77%-19.81M
101.28%122.1K
-19.48%16.34M
-Interest expense (Financial expense)
-1.36%15.41M
44.56%66.1M
62.80%49.35M
115.69%32.23M
308.07%15.62M
397.83%45.72M
416.68%30.32M
346.74%14.94M
574.23%3.83M
1,356.60%9.18M
-Interest Income (Financial expense)
4.78%-4.04M
4.44%-13.44M
-177.99%-19.83M
-94.80%-8.5M
-174.72%-4.25M
-24.81%-14.06M
5.03%-7.13M
19.62%-4.36M
50.73%-1.55M
-177.96%-11.27M
Research and development
-28.68%34.51M
0.50%169.17M
9.35%132.53M
28.75%92.47M
75.81%48.39M
47.62%168.32M
48.79%121.2M
41.36%71.82M
-6.42%27.53M
25.40%114.02M
Credit Impairment Loss
155.63%1.07M
-40.49%-9.95M
1.44%-6.79M
69.24%-2.55M
8.14%-1.91M
-194.06%-7.08M
-580.63%-6.88M
-609.30%-8.3M
-141.26%-2.08M
50.40%-2.41M
Asset Impairment Loss
-557.63%-7.75M
-309.47%-37.72M
-334.66%-21.08M
-442.31%-20.58M
-9.70%-1.18M
3.08%-9.21M
-24.40%-4.85M
-30.49%-3.8M
-88.04%-1.07M
-318.10%-9.5M
Other net revenue
-95.34%581.93K
-3,091.56%-53.39M
-126.91%-63.8M
-141.57%-47.74M
1,370.17%12.49M
-100.73%-1.67M
-112.06%-28.11M
-108.62%-19.76M
-113.40%-983.23K
5,150.01%227.95M
Fair value change income
-1.62%8.17M
-1,173.63%-21.33M
-168.62%-55.72M
-276.54%-41.58M
--8.3M
18.70%1.99M
-1,544.77%-20.74M
-1,166.26%-11.04M
----
--1.67M
Invest income
-128.47%-2.07M
-10.13%11.35M
356.12%19.89M
402.15%16.98M
234.76%7.28M
-94.70%12.63M
-98.14%4.36M
-98.53%3.38M
-23.81%2.18M
9,009.52%238.15M
-Including: Investment income associates
----
75.93%-1.72M
84.14%-1.02M
67.25%-1.08M
----
-60.83%-7.15M
-74.94%-6.42M
10.39%-3.31M
----
-1,129.34%-4.44M
Asset deal income
----
--416.67K
---108.15K
----
----
----
----
----
----
--35.44K
Other revenue
--1.17M
--3.83M
----
----
----
----
----
----
----
----
Operating profit
3.72%52.84M
-37.78%184.6M
-47.78%137.94M
-45.82%90.76M
-36.29%50.94M
-39.81%296.71M
-43.07%264.14M
-57.67%167.5M
9.98%79.96M
153.93%492.96M
Add:Non operating Income
-12.79%2.77M
30.22%41.06M
69.30%32.5M
281.86%30.33M
-6.85%3.18M
109.57%31.53M
107.42%19.2M
19.49%7.94M
-12.19%3.41M
42.46%15.05M
Less:Non operating expense
-90.69%5.77K
-13.85%4.29M
-64.02%300.23K
-73.33%212.92K
-83.62%62.02K
2,033.70%4.97M
317.08%834.53K
527.04%798.34K
--378.62K
26.97%233.12K
Total profit
2.86%55.6M
-31.52%221.38M
-39.77%170.14M
-30.79%120.88M
-34.86%54.06M
-36.34%323.26M
-40.28%282.5M
-56.58%174.65M
8.36%82.99M
148.29%507.77M
Less:Income tax cost
265.58%6.12M
1,013.96%24.01M
-24.15%16.09M
-29.29%6.99M
-142.84%-3.7M
-165.64%-2.63M
-3.06%21.21M
-39.98%9.89M
26.54%8.63M
-80.28%4M
Net profit
-14.32%49.49M
-39.44%197.36M
-41.04%154.05M
-30.88%113.89M
-22.34%57.76M
-35.31%325.89M
-42.09%261.29M
-57.29%164.76M
6.59%74.37M
173.48%503.77M
Net profit from continuing operation
-14.32%49.49M
-39.44%197.36M
-41.04%154.05M
-30.88%113.89M
-22.34%57.76M
-35.31%325.89M
-42.09%261.29M
-57.29%164.76M
6.59%74.37M
173.48%503.77M
Less:Minority Profit
----
-100.00%-14.46
-100.00%-14.47
-100.00%-14.47
-100.00%-8.4
-32.20%11.67M
32.73%11.67M
157.56%11.67M
2,007,714.53%3.53M
543,980.77%17.21M
Net profit of parent company owners
-14.32%49.49M
-37.19%197.36M
-38.29%154.05M
-25.61%113.89M
-18.47%57.76M
-35.42%314.22M
-43.57%249.62M
-59.84%153.1M
1.53%70.84M
164.14%486.56M
Earning per share
Basic earning per share
-13.79%0.25
-37.34%0.99
-38.62%0.7715
-25.97%0.57
-19.44%0.29
-35.77%1.58
-43.88%1.257
-60.10%0.77
2.86%0.36
148.48%2.46
Diluted earning per share
-17.24%0.24
-37.58%0.98
-38.57%0.7679
-25.97%0.57
-17.14%0.29
-35.66%1.57
-43.57%1.2501
-59.69%0.77
0.00%0.35
148.98%2.44
Other composite income
111.32%141.53K
206.05%1.51M
761.89%2.86M
733.59%3.88M
-422.51%-1.25M
-359.42%-1.43M
181.06%331.26K
204.77%465.09K
-531.60%-239.22K
80.34%-310.38K
Other composite income of parent company owners
111.32%141.53K
206.05%1.51M
761.89%2.86M
733.59%3.88M
-422.51%-1.25M
-359.42%-1.43M
181.06%331.26K
204.77%465.09K
-531.60%-239.22K
80.34%-310.38K
Total composite income
-12.17%49.63M
-38.71%198.87M
-40.03%156.9M
-28.72%117.77M
-23.77%56.51M
-35.55%324.46M
-41.96%261.62M
-57.12%165.23M
6.16%74.13M
175.68%503.46M
Total composite income of parent company owners
-12.17%49.63M
-36.42%198.87M
-37.23%156.9M
-23.31%117.77M
-19.96%56.51M
-35.67%312.8M
-43.45%249.95M
-59.67%153.56M
1.11%70.6M
166.25%486.25M
Total composite income of minority owners
----
-100.00%-14.46
-100.00%-14.47
-100.00%-14.47
-100.00%-8.4
-32.20%11.67M
32.73%11.67M
157.56%11.67M
2,007,714.53%3.53M
543,980.77%17.21M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
--
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -1.56%377.46M8.18%1.73B9.01%1.29B14.89%844.06M14.24%383.44M32.71%1.59B31.21%1.18B18.23%734.64M17.44%335.64M17.55%1.2B
Operating revenue -1.56%377.46M8.18%1.73B9.01%1.29B14.89%844.06M14.24%383.44M32.71%1.59B31.21%1.18B18.23%734.64M17.44%335.64M17.55%1.2B
Other operating revenue -----7.91%451.99K----9.35%220.55K----37.32%490.8K----283.29%201.68K----168.79%357.42K
Total operating cost -5.73%325.2M14.73%1.49B22.11%1.09B28.90%705.56M35.45%344.99M38.40%1.3B32.81%892.45M20.33%547.38M15.54%254.7M13.72%936.62M
Operating cost 3.01%216.31M14.05%991.67M18.16%737.71M23.83%475.39M19.50%209.99M39.49%869.5M36.47%624.35M22.69%383.9M17.05%175.73M12.48%623.34M
Operating tax surcharges 54.13%5.1M56.71%18.63M46.11%9.83M71.33%7.24M106.34%3.31M43.63%11.89M4.59%6.73M-16.50%4.23M117.41%1.6M30.02%8.28M
Operating expense 8.08%14.12M29.91%53.21M32.88%41.16M37.53%27.09M27.24%13.06M68.65%40.96M26.40%30.97M12.66%19.7M4.79%10.26M-20.80%24.28M
Administration expense -4.64%47.05M-3.52%200.23M-0.53%148.75M15.24%100.88M25.03%49.33M38.03%207.53M47.11%149.54M33.86%87.54M-1.04%39.46M24.08%150.35M
Financial expense -61.16%8.12M2,996.37%54.3M148.95%19.75M112.57%2.49M17,016.90%20.9M-111.47%-1.87M-8,813.32%-40.35M-706.77%-19.81M101.28%122.1K-19.48%16.34M
-Interest expense (Financial expense) -1.36%15.41M44.56%66.1M62.80%49.35M115.69%32.23M308.07%15.62M397.83%45.72M416.68%30.32M346.74%14.94M574.23%3.83M1,356.60%9.18M
-Interest Income (Financial expense) 4.78%-4.04M4.44%-13.44M-177.99%-19.83M-94.80%-8.5M-174.72%-4.25M-24.81%-14.06M5.03%-7.13M19.62%-4.36M50.73%-1.55M-177.96%-11.27M
Research and development -28.68%34.51M0.50%169.17M9.35%132.53M28.75%92.47M75.81%48.39M47.62%168.32M48.79%121.2M41.36%71.82M-6.42%27.53M25.40%114.02M
Credit Impairment Loss 155.63%1.07M-40.49%-9.95M1.44%-6.79M69.24%-2.55M8.14%-1.91M-194.06%-7.08M-580.63%-6.88M-609.30%-8.3M-141.26%-2.08M50.40%-2.41M
Asset Impairment Loss -557.63%-7.75M-309.47%-37.72M-334.66%-21.08M-442.31%-20.58M-9.70%-1.18M3.08%-9.21M-24.40%-4.85M-30.49%-3.8M-88.04%-1.07M-318.10%-9.5M
Other net revenue -95.34%581.93K-3,091.56%-53.39M-126.91%-63.8M-141.57%-47.74M1,370.17%12.49M-100.73%-1.67M-112.06%-28.11M-108.62%-19.76M-113.40%-983.23K5,150.01%227.95M
Fair value change income -1.62%8.17M-1,173.63%-21.33M-168.62%-55.72M-276.54%-41.58M--8.3M18.70%1.99M-1,544.77%-20.74M-1,166.26%-11.04M------1.67M
Invest income -128.47%-2.07M-10.13%11.35M356.12%19.89M402.15%16.98M234.76%7.28M-94.70%12.63M-98.14%4.36M-98.53%3.38M-23.81%2.18M9,009.52%238.15M
-Including: Investment income associates ----75.93%-1.72M84.14%-1.02M67.25%-1.08M-----60.83%-7.15M-74.94%-6.42M10.39%-3.31M-----1,129.34%-4.44M
Asset deal income ------416.67K---108.15K--------------------------35.44K
Other revenue --1.17M--3.83M--------------------------------
Operating profit 3.72%52.84M-37.78%184.6M-47.78%137.94M-45.82%90.76M-36.29%50.94M-39.81%296.71M-43.07%264.14M-57.67%167.5M9.98%79.96M153.93%492.96M
Add:Non operating Income -12.79%2.77M30.22%41.06M69.30%32.5M281.86%30.33M-6.85%3.18M109.57%31.53M107.42%19.2M19.49%7.94M-12.19%3.41M42.46%15.05M
Less:Non operating expense -90.69%5.77K-13.85%4.29M-64.02%300.23K-73.33%212.92K-83.62%62.02K2,033.70%4.97M317.08%834.53K527.04%798.34K--378.62K26.97%233.12K
Total profit 2.86%55.6M-31.52%221.38M-39.77%170.14M-30.79%120.88M-34.86%54.06M-36.34%323.26M-40.28%282.5M-56.58%174.65M8.36%82.99M148.29%507.77M
Less:Income tax cost 265.58%6.12M1,013.96%24.01M-24.15%16.09M-29.29%6.99M-142.84%-3.7M-165.64%-2.63M-3.06%21.21M-39.98%9.89M26.54%8.63M-80.28%4M
Net profit -14.32%49.49M-39.44%197.36M-41.04%154.05M-30.88%113.89M-22.34%57.76M-35.31%325.89M-42.09%261.29M-57.29%164.76M6.59%74.37M173.48%503.77M
Net profit from continuing operation -14.32%49.49M-39.44%197.36M-41.04%154.05M-30.88%113.89M-22.34%57.76M-35.31%325.89M-42.09%261.29M-57.29%164.76M6.59%74.37M173.48%503.77M
Less:Minority Profit -----100.00%-14.46-100.00%-14.47-100.00%-14.47-100.00%-8.4-32.20%11.67M32.73%11.67M157.56%11.67M2,007,714.53%3.53M543,980.77%17.21M
Net profit of parent company owners -14.32%49.49M-37.19%197.36M-38.29%154.05M-25.61%113.89M-18.47%57.76M-35.42%314.22M-43.57%249.62M-59.84%153.1M1.53%70.84M164.14%486.56M
Earning per share
Basic earning per share -13.79%0.25-37.34%0.99-38.62%0.7715-25.97%0.57-19.44%0.29-35.77%1.58-43.88%1.257-60.10%0.772.86%0.36148.48%2.46
Diluted earning per share -17.24%0.24-37.58%0.98-38.57%0.7679-25.97%0.57-17.14%0.29-35.66%1.57-43.57%1.2501-59.69%0.770.00%0.35148.98%2.44
Other composite income 111.32%141.53K206.05%1.51M761.89%2.86M733.59%3.88M-422.51%-1.25M-359.42%-1.43M181.06%331.26K204.77%465.09K-531.60%-239.22K80.34%-310.38K
Other composite income of parent company owners 111.32%141.53K206.05%1.51M761.89%2.86M733.59%3.88M-422.51%-1.25M-359.42%-1.43M181.06%331.26K204.77%465.09K-531.60%-239.22K80.34%-310.38K
Total composite income -12.17%49.63M-38.71%198.87M-40.03%156.9M-28.72%117.77M-23.77%56.51M-35.55%324.46M-41.96%261.62M-57.12%165.23M6.16%74.13M175.68%503.46M
Total composite income of parent company owners -12.17%49.63M-36.42%198.87M-37.23%156.9M-23.31%117.77M-19.96%56.51M-35.67%312.8M-43.45%249.95M-59.67%153.56M1.11%70.6M166.25%486.25M
Total composite income of minority owners -----100.00%-14.46-100.00%-14.47-100.00%-14.47-100.00%-8.4-32.20%11.67M32.73%11.67M157.56%11.67M2,007,714.53%3.53M543,980.77%17.21M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Notarized Tianye Certified Public Accountants (Special General Partnership)------Zhongtianyun Certified Public Accountants (Special General Partnership)------Zhongtianyun Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg